1,069 results on '"Yopp, Adam"'
Search Results
2. ASO Visual Abstract: The Prognostic Significance of Nativity, Enclave Residence, and Socioeconomic Status Among Hispanics with Hepatocellular Carcinoma
3. Correction to: Lenvatinib inhibits the growth of gastric cancer patient‑derived xenografts generated from a heterogeneous populations
4. The phosphatidylserine targeting antibody bavituximab plus pembrolizumab in unresectable hepatocellular carcinoma: a phase 2 trial
5. Effect of Hospital Cancer Designation on use of Multimodal Therapy and Survival of Metastatic Colorectal Cancer: A State-Wide Analysis
6. Delta Radiomic Features Predict Resection Margin Status and Overall Survival in Neoadjuvant-Treated Pancreatic Cancer Patients
7. Cost Analysis and Financial Implications of a Peritoneal Surface Malignancy Program in the USA
8. ASO Visual Abstract: Effect of Hospital Cancer Designation on Use of Multimodal Therapy and Survival of Patients with Metastatic Colorectal Cancer: A State-Wide Analysis
9. Impact of Neoadjuvant Treatment and Minimally Invasive Surgery on Perioperative Outcomes of Pancreatoduodenectomy: an ACS NSQIP Analysis
10. Current Practices in Hepatic Artery Infusion (HAI) Chemotherapy: An International Survey of the HAI Consortium Research Network
11. PKD1 mutant clones within cirrhotic livers inhibit steatohepatitis without promoting cancer
12. ASO Visual Abstract: Delta Radiomic Features Predict Resection Margin Status and Overall Survival in Neoadjuvant-Treated Pancreatic Cancer Patients
13. Evaluating the safety and efficacy of a novel polysaccharide hemostatic system during surgery: A multicenter multispecialty prospective randomized controlled trial
14. Minimally invasive pancreaticoduodenectomy: A favorable approach for frail patients with pancreatic cancer
15. Presence of underlying cirrhosis is associated with increased in-hospital mortality and length of stay following pancreatoduodenectomy
16. Association of race, demographic and socioeconomic factors with failure to rescue after hepato-pancreato-biliary surgery in the United States
17. Hepatocellular Carcinoma Surveillance Patterns and Outcomes in Patients With Cirrhosis
18. ASO Visual Abstract: Cost Analysis and Financial Implications of a Peritoneal Surface Malignancy Program in the United States
19. Robotic versus open pancreaticoduodenectomy in octogenarians: a comparative propensity score analysis of perioperative outcomes
20. Association of hospital markup with preventable adverse events following pancreatic surgery in the United States
21. Expanding Indications for Surgical Resection in Hepatocellular Carcinoma: What is the Evidence?
22. ASO Visual Abstract: Current Practices in Hepatic Artery Infusion (HAI) Chemotherapy—An International Survey of the HAI Consortium Research Network
23. Hospital Designations and Their Impact on Guideline-Concordant Care and Survival in Pancreatic Cancer. Do They Matter?
24. Atezolizumab plus bevacizumab versus active surveillance in patients with resected or ablated high-risk hepatocellular carcinoma (IMbrave050): a randomised, open-label, multicentre, phase 3 trial
25. Defining the Price Tag of Complications Following Pancreatic Surgery: A US National Perspective
26. Variation of Hepatocellular Carcinoma Treatment Patterns and Survival Across Geographic Regions in a Veteran Population
27. Racial and Ethnic Disparities in Barriers to Care in Patients with Hepatocellular Carcinoma
28. Risk of Hepatocellular Carcinoma in Patients With Indeterminate (LI-RADS 3) Liver Observations
29. Trends and Disparities in Treatment Utilization for Early-Stage Hepatocellular Carcinoma in the Veteran Population
30. Association Between Biliary Pathogens, Surgical Site Infection, and Pancreatic Fistula: Results of a Randomized Trial of Perioperative Antibiotic Prophylaxis in Patients Undergoing Pancreatoduodenectomy
31. Implications of the interaction between travel burden and area deprivation for patients with pancreatic cancer
32. An Overview of Clinical Trials in the Treatment of Resectable Hepatocellular Carcinoma
33. High Neutrophil–Lymphocyte Ratio and Delta Neutrophil–Lymphocyte Ratio Are Associated with Increased Mortality in Patients with Hepatocellular Cancer
34. Nativity Status is an Important Social Determinant of Health for Hispanic Patients with Gastric Cancer in Texas
35. Considerations and barriers to starting a new HAI pump program: an international survey of the HAI Consortium Research Network
36. ASO Visual Abstract: Hospital Designations and Their Impact on Guideline-Concordant Care and Survival in Pancreatic Cancer: Do They Matter?
37. Dynamic Changes in Ultrasound Quality for Hepatocellular Carcinoma Screening in Patients With Cirrhosis
38. Cachexia is Prevalent in Patients With Hepatocellular Carcinoma and Associated With Worse Prognosis
39. Lenvatinib inhibits the growth of gastric cancer patient-derived xenografts generated from a heterogeneous population
40. Racial and Ethnic Disparities in Survival Among Patients With Hepatocellular Carcinoma in the United States: A Systematic Review and Meta-Analysis
41. Comparing barriers to early stage diagnosis of hepatocellular carcinoma between safety net hospitals and academic medical centers: An analysis from the United States Safety‐Net Collaborative.
42. A Novel T-Stage Classification System for Adrenocortical Carcinoma: Proposal from the US Adrenocortical Carcinoma Study Group
43. Defining the Role of Social Vulnerability in Treatment and Survival in Localized Colon Cancer
44. Outcome of Hepatocellular Carcinoma Detected During Surveillance: Comparing USA and Japan
45. Benefits and Harms of Hepatocellular Carcinoma Surveillance in a Prospective Cohort of Patients With Cirrhosis
46. Cumulative GRAS Score as a Predictor of Survival After Resection for Adrenocortical Carcinoma: Analysis From the U.S. Adrenocortical Carcinoma Database
47. Redefining High-Volume Gastric Cancer Centers: The Impact of Operative Volume on Surgical Outcomes
48. LI-RADS treatment response algorithm after first-line DEB-TACE: reproducibility and prognostic value at initial post-treatment CT/MRI
49. A blood-based prognostic liver secretome signature and long-term hepatocellular carcinoma risk in advanced liver fibrosis
50. Survival inequity in vulnerable populations with early-stage hepatocellular carcinoma: a United States safety-net collaborative analysis
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.